scholarly journals Neuronal Cells Rearrangement During Aging and Neurodegenerative Disease: Metabolism, Oxidative Stress and Organelles Dynamic

Author(s):  
Vanessa Castelli ◽  
Elisabetta Benedetti ◽  
Andrea Antonosante ◽  
Mariano Catanesi ◽  
Giuseppina Pitari ◽  
...  
2019 ◽  
Author(s):  
Yilin Kang ◽  
Alexander J. Anderson ◽  
David P. De Souza ◽  
Catherine S. Palmer ◽  
Kenji M. Fujihara ◽  
...  

AbstractHuman Tim8a is a member of an intermembrane space chaperone network, known as the small TIM family, which transport hydrophobic membrane proteins through this compartment. Mutations in TIMM8A cause a neurodegenerative disease, Mohr-Tranebjærg syndrome (MTS), which is characterised by sensorineural hearing loss, dystonia and blindness. Nothing is known about the function of hTim8a in neuronal cells and consequently how lack of hTim8a leads to a neurodegenerative disease. We identified a novel cell-specific function of hTim8a in the assembly of Complex IV, which is mediated through a transient interaction with the copper chaperone COX17. Complex IV assembly defects in cells lacking hTim8a leads to oxidative stress and changes to key apoptotic regulators, including cytochrome c and Bax, which primes cells for cell death. Alleviation of oxidative stress using Vitamin E rescues cells from apoptotic vulnerability. We hypothesis that enhanced sensitivity of neuronal cells to apoptosis is the underlying mechanism of MTS.


eLife ◽  
2019 ◽  
Vol 8 ◽  
Author(s):  
Yilin Kang ◽  
Alexander J Anderson ◽  
Thomas Daniel Jackson ◽  
Catherine S Palmer ◽  
David P De Souza ◽  
...  

Human Tim8a and Tim8b are members of an intermembrane space chaperone network, known as the small TIM family. Mutations in TIMM8A cause a neurodegenerative disease, Mohr-Tranebjærg syndrome (MTS), which is characterised by sensorineural hearing loss, dystonia and blindness. Nothing is known about the function of hTim8a in neuronal cells or how mutation of this protein leads to a neurodegenerative disease. We show that hTim8a is required for the assembly of Complex IV in neurons, which is mediated through a transient interaction with Complex IV assembly factors, in particular the copper chaperone COX17. Complex IV assembly defects resulting from loss of hTim8a leads to oxidative stress and changes to key apoptotic regulators, including cytochrome c, which primes cells for death. Alleviation of oxidative stress with Vitamin E treatment rescues cells from apoptotic vulnerability. We hypothesise that enhanced sensitivity of neuronal cells to apoptosis is the underlying mechanism of MTS.


Data in Brief ◽  
2018 ◽  
Vol 21 ◽  
pp. 1872-1879 ◽  
Author(s):  
Malena Rabenau ◽  
Matthias Unger ◽  
Jürgen Drewe ◽  
Carsten Culmsee

Author(s):  
Selva Rivas-Arancibia ◽  
Cesar Gallegos-Rios ◽  
Nancy Gomez-Crisostomo ◽  
Ever Ferreira-Garciduenas ◽  
Dulce Flores ◽  
...  

2011 ◽  
Vol 51 (2) ◽  
pp. 248-249 ◽  
Author(s):  
Xiongwei Zhu ◽  
Rudy J. Castellani ◽  
Hyoung-gon Lee ◽  
George Perry

Neuroscience ◽  
2011 ◽  
Vol 175 ◽  
pp. 281-291 ◽  
Author(s):  
S. Kaja ◽  
R.S. Duncan ◽  
S. Longoria ◽  
J.D. Hilgenberg ◽  
A.J. Payne ◽  
...  

Dose-Response ◽  
2021 ◽  
Vol 19 (4) ◽  
pp. 155932582110443
Author(s):  
Paul A. Oakley

A subset of victims who experience concussion suffer from persistent symptoms spanning months to years post-injury, termed post-concussion syndrome (PCS). Problematically, there is lack of consensus for the treatment of PCS. Concussion injury involves a neurometabolic cascade leading to oxidative stress and neuroinflammation which parallels the oxidative stress loading occuring from age-related neurodegenerative conditions. Historical and recent evidence has emerged showing the efficacy of low-dose radiation therapy for many human diseases including neurodegenerative diseases such as Alzhiemer’s disease (AD). Due to the pathognomonic similarities of oxidative stress and neuroinflammation involved in PCS and neurodegenerative disease, treatments that prove successful for neurodegenerative disease may prove successful for PCS. Recently, low-dose ionizing radiation therapy (LDIR) has been documented to show a reversal of many symptoms in AD, including improved cognition. LDIR is thought to induce a switching from proinflammatory M1 phenotype to an anti-inflammatory M2 phenotype. In other words, a continual upregulation of the adaptive protection systems via LDIR induces health enhancement. It is hypothesized LDIR treatment for PCS would mimic that seen from early evidence of LDIR treatment of AD patients who suffer from similar oxidative stress loading. We propose the application of LDIR is a promising, untapped treatment for PCS.


2019 ◽  
Vol 27 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Suk Ju Cho ◽  
Kyoung Ah Kang ◽  
Mei Jing Piao ◽  
Yea Seong Ryu ◽  
Pincha Devage Sameera Madushan Fernando ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document